KCL are looking to appoint an enthusiastic post-doctoral Research Associate to work on an exciting, international, research study of take home naloxone. This is a mixed-methods study of the effectiveness of take home naloxone administration by lay people in reversing opioid overdose. The study aims to determine a) the rate of naloxone administration with the intention of reversing an opioid overdose by lay persons provided with THN who witness an opioid overdose and b) the frequency of deaths in the 24 hours subsequent to administration of naloxone. The post is fixed term for two years.
Even though the study is funded by MundiPharma Research Ltd (the pharmaceutical company responsible for manufacturing the nasal naloxone, Nyxoid), the study examines any/all forms of naloxone which participating clinical services provide. The study is being undertaken in England, Wales, Scotland, Denmark and Sweden (and other countries, to be confirmed). The post holder will be located in the Addictions Department at the IoPPN, King’s College London.
A cohort of 6000 individuals having been pre-supplied with naloxone will be followed up over six months to determine whether they have witnessed (or experienced) an overdose. Those that have will be asked to take part in an interview with a researcher to ask them to provide more details about the overdose event.
The position will involve assisting with every aspect of this study including:
liaising with countries to ensure recruitment of country sites and participants and adherence to protocol, ensuring countries have the training and resources they need; management and reporting of serious adverse events and assisting with data analysis and report writing, maintaining up to date study files and databases, and undertaking research interviews over the telephone and data entry for participants recruited in London.
